Correlation Between Shanghai Rongtai and Maccura Biotechnology

Can any of the company-specific risk be diversified away by investing in both Shanghai Rongtai and Maccura Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shanghai Rongtai and Maccura Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Shanghai Rongtai Health and Maccura Biotechnology Co, you can compare the effects of market volatilities on Shanghai Rongtai and Maccura Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shanghai Rongtai with a short position of Maccura Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shanghai Rongtai and Maccura Biotechnology.

Diversification Opportunities for Shanghai Rongtai and Maccura Biotechnology

0.91

Correlation Coefficient

Shanghai Rongtai  Maccura Biotechnology

Almost no diversification

The 3 months correlation between Shanghai and Maccura is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Shanghai Rongtai Health and Maccura Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maccura Biotechnology and Shanghai Rongtai is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shanghai Rongtai Health are associated (or correlated) with Maccura Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maccura Biotechnology has no effect on the direction of Shanghai Rongtai i.e., Shanghai Rongtai and Maccura Biotechnology go up and down completely randomly.

Pair Corralation between Shanghai Rongtai and Maccura Biotechnology

Assuming the 90 days trading horizon Shanghai Rongtai Health is expected to generate 0.78 times more return on investment than Maccura Biotechnology. However, Shanghai Rongtai Health is 1.29 times less risky than Maccura Biotechnology. It trades about 0.17 of its potential returns per unit of risk. Maccura Biotechnology Co is currently generating about 0.11 per unit of risk. If you would invest  1,169  in Shanghai Rongtai Health on September 2, 2024 and sell it today you would earn a total of  317.00  from holding Shanghai Rongtai Health or generate 27.12% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Shanghai Rongtai Health  vs.  Maccura Biotechnology Co

Shanghai Rongtai Health

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Rongtai Health are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shanghai Rongtai sustained solid returns over the last few months and may actually be approaching a breakup point.

Maccura Biotechnology

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Maccura Biotechnology Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Maccura Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Shanghai Rongtai and Maccura Biotechnology

The main advantage of trading using opposite Shanghai Rongtai and Maccura Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shanghai Rongtai position performs unexpectedly, Maccura Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maccura Biotechnology will offset losses from the drop in Maccura Biotechnology's long position.

The idea behind Shanghai Rongtai Health and Maccura Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..